Chronic hepatitis C

Autor: Yves Deugnier, Zeineb Ben Ali, Isabelle Renard, Caroline Jezequel, Jean-Baptiste Nousbaum, Antonia Le Gruyer, Jean-François Cadranel, Marianne Latournerie, Michel Robaszkiewicz, Marie Feillant, Florence Tanné, Armand Garioud, Hortensia Lison, Dominique Guyader, Aurélien Delluc

Publikováno v: European Journal of Gastroenterology and Hepatology
European Journal of Gastroenterology and Hepatology, Lippincott, Williams & Wilkins, 2016, 28 (2), pp.164-72. ⟨10.1097/MEG.0000000000000506⟩
European Journal of Gastroenterology & Hepatology
European Journal of Gastroenterology & Hepatology, 2016, 28 (2), pp.164-72. ⟨10.1097/MEG.0000000000000506⟩

International audience; BACKGROUND AND AIMS: In many countries, current treatment for patients with chronic hepatitis C involves a combination of peginterferon and ribavirin, associated with a protease inhibitor for hepatitis C virus genotype 1. More

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91504cb9d32af38759586909b7c3e47f
https://doi.org/10.1097/meg.0000000000000506